Seroatlas · Human Serome Atlas

IGFBP6

Insulin-like growth factor-binding protein 6

Also known as: IBP6_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P24592
Gene
IGFBP6
Ensembl
ENSG00000167779
Chromosome
12
Canonical length
240 aa
Protein class
Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
Secretome location
Secreted to blood

OverviewNCBI Gene

Enables identical protein binding activity and insulin-like growth factor II binding activity. Involved in cell migration and positive regulation of stress-activated MAPK cascade. Part of insulin-like growth factor binary complex. Implicated in obesity. Biomarker of breast cancer; in situ carcinoma; leiomyoma; and neovascular inflammatory vitreoretinopathy. [provided by Alliance of Genome Resources, Jul 2025]

Canonical amino-acid sequenceUniProt

240 residues, UniProt reviewed canonical sequence.

>P24592|IGFBP6
     1  MTPHRLLPPL LLLLALLLAA SPGGALARCP GCGQGVQAGC PGGCVEEEDG GSPAEGCAEA
    61  EGCLRREGQE CGVYTPNCAP GLQCHPPKDD EAPLRALLLG RGRCLPARAP AVAEENPKES
   121  KPQAGTARPQ DVNRRDQQRN PGTSTTPSQP NSAGVQDTEM GPCRRHLDSV LQQLQTEVYR
   181  GAQTLYVPNC DHRGFYRKRQ CRSSQGQRRG PCWCVDRMGK SLPGSPDGNG SSSCPTGSSG

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against IGFBP6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Secreted
Secreted
Yes
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.53
Highest tissue expression
787 nTPM

Expression across tissuesHPA

Tissue

  • blood vessel: 787 nTPM
  • cervix: 552 nTPM
  • fallopian tube: 529 nTPM
  • vagina: 512 nTPM
  • breast: 395 nTPM
  • adipose tissue: 354 nTPM

Single-cell type

  • fibroblasts: 2,166 nCPM
  • decidual stromal cells: 1,550 nCPM
  • peritubular myoid cells: 1,382 nCPM
  • leydig cells: 721 nCPM
  • pericytes: 663 nCPM
  • hepatic stellate cells: 633 nCPM

Immune cell

  • eosinophil: 32 nTPM
  • non-classical monocyte: 20 nTPM
  • naive CD8 T-cell: 6.9 nTPM
  • intermediate monocyte: 6.8 nTPM
  • memory CD8 T-cell: 5.4 nTPM
  • MAIT T-cell: 3.4 nTPM

Brain region

  • choroid plexus: 108 nTPM
  • thalamus: 46 nTPM
  • spinal cord: 33 nTPM
  • hypothalamus: 25 nTPM
  • pons: 24 nTPM
  • basal ganglia: 24 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.92
gnomAD pLI
0.03
gnomAD missense Z
0.23
DepMap mean gene effect
-0.11
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of IGFBP6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads IGFBP6 as an antibody target. Whether an autoantibody or antibody against IGFBP6 could matter depends on whether native IGFBP6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

IGFBP6 is annotated as secreted, so native IGFBP6 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.

Annotation status

The present source text does not explicitly label IGFBP6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/IGFBP6. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...